Aap Implantate Ag · XETR:AAQ1
Aap Implantate — 9M 2017 Earnings Presentation
10 slides from Aap Implantate's earnings presentation, Nov 15, 2017
Slide 1: aap Implantate AG Q3/9M 2017 Report Conference Call
aap Implantate AG Q3/9M 2017 Report Conference Call Bruke Seyoum Alemu, CEO Marek Hahn, CFO Berlin, November 15, 2017
Slide 2: Safe Harbor Statement
Safe Harbor Statement Our publication may include predictions, estimates or other information that might be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual
Slide 3: Implementation of Strategic Imperatives
Implementation of Strategic Imperatives Progress in Q3/9M 2017 Products Customers Accelerating Value-based Innovation Enhancing Enhancing Market Market Access Access LOQTEQ®: Completion of development activities in Established Established countries: countries: Focus Northon DACH,and Western DA
Slide 4: Financial Figures Q3/9M 2017 (1/3)
Financial Figures Q3/9M 2017 (1/3) (in KEUR) Sales Q3/2017 Q3/2016 Change Sales 2,595 2,875 -10% Trauma 2,574 2,325 +11% North America 733 641 +14% DACH 668 648 +3% Europe w/o DACH 256 434 -41% RoW 917 602 +52% Other (mainly discontinued activities) 21 550 -96% Sales 9M/2017 9M/2016 Change Sales (re
Slide 5: Financial Figures Q3/9M 2017 (2/3)
Financial Figures Q3/9M 2017 (2/3) (in KEUR and EUR million) EBITDA Q3/2017 Q3/2016 Change EBITDA -1,567 -1,764 +11% One-time effects 286* 315** -9% Recurring EBITDA -1,281 -1,449 +12% *Includes costs of evaluating strategic options, costs of “Quality First” project, costs of share buyback program a
Slide 6: Financial Figures 9M/2017 (3/3)
Financial Figures 9M/2017 (3/3) (EBITDA bridge 9M/2016 to 9M/2017 in KEUR) 6
Slide 7: Highlights 9M/2017 (Balance Sheet)
Highlights 9M/2017 (Balance Sheet) • Total assets 09/30/2017: EUR 52.3 million (12/31/2016: EUR 63.9 million) -17% Non-current assets: Change EUR -0.6 million Capitalized development costs: EUR +0.3 million; Share of intangible assets in total assets: 22% Healthy ratio Tangible assets: EUR
Slide 8: Highlights 9M/2017 (Cash Flow)
Highlights 9M/2017 (Cash Flow) • Operating Cash Flow 9M/2017: EUR -4.4 million (9M/2016: EUR -5.0 million) Improved operating result Positive contribution from working capital reduction of EUR 0.4 million main impact reduction of inventory of EUR +0.4 million, receivables EUR +0.3 million and
Slide 9: Outlook FY/2017
Outlook FY/2017 FY/2017 – Sales: EUR 10.0 million – EUR 13.0 million (FY/2016: EUR 10.5 million) – EBITDA: EUR -6.5 million – EUR -4.5 million (FY/2016: EUR -7.9 million) Against the background of the results realized in the year to date and the outlook for the fourth quarter, sales and EBITDA are e
Slide 10: Many thanks for your attention!
Many thanks for your attention! Lorenzweg 5 • 12099 Berlin • Germany Fabian Franke Manager Investor Relations Tel.: +49 30 750 19 – 134 Fax: +49 30 750 19 – 290 E-Mail: ir@aap.de IR-app: 10